RAND tests whether AI agents can select and operate biological design tools used in bioweapon pathways

arXiv · Research preprint

Read the source (opens in a new tab)
What happened
RAND's Center on AI, Security, and Technology posted a 78-page report (RR-A4741-1) on arXiv on October 2, 2026, assessing how seven frontier LLM agents interact with specialized biological tools.
Key points
  • It finds agents can perform many initial interactions with biological tools, which may help nonexpert actors use them and warrants more targeted testing.
  • Many models scored at or near 80% at identifying tools for specific functions, but accuracy dropped in contextualized design scenarios, and closed-weight models often refused risk-relevant questions.
  • Agents showed some ability to operate EVEscape, for immune-evasion prediction, and ESM3, for protein redesign, but reliability was mixed and varied by protein.
  • Adding more biological detail to prompts did not reliably improve performance.
Evidence
RAND research report, quality-assured by RAND and posted to arXiv. Results come from computational tests, not laboratory work.
Uncertain
RAND frames this as an assessment of early-stage interactions and a foundation for further work as tools advance.

See it in the latest record